For today’s episode we will be reviewing three articles about asthma from the May-June 2019 issue of Allergy Watch:

https://www.ncbi.nlm.nih.gov/pubmed/30217529

https://www.ncbi.nlm.nih.gov/pubmed/30205189

https://www.ncbi.nlm.nih.gov/pubmed/30612667

https://www.ncbi.nlm.nih.gov/pubmed/30107059/

https://www.ncbi.nlm.nih.gov/pubmed/29301922

Please give us feedback, corrections, and suggestions!

Email feedback to: [email protected]

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Today’s speakers have the following disclosures:

Dr. Lee was on an advisory board for Teva.

Dr. Kalangara has received consulting fees from Astra Zenica.

Dr. Fineman 

Speaker: AstraZenca, Boehringer Ingelheim, Shire

Research: Aimmune, DBV, Shire, Regeneron.